Amiodarone (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "Amiodarone" in French language version.

refsWebsite

Global rank French rank

5nih.gov

4^th place

12^th place

4nejm.org

2,374^th place

298^th place

3ahajournals.org

3,608^th place

659^th place

2sciencedirect.com

149^th place

80^th place

1qmul.ac.uk

1,735^th place

168^th place

1bmj.com

1,226^th place

347^th place

1nature.com

234^th place

147^th place

1onlinejacc.org

low place

2,587^th place

1springer.com

274^th place

223^rd place

1endocrine.org

low place

8,434^th place

1surveyophthalmol.com

low place

1wiley.com

222^nd place

129^th place

1who.int

195^th place

221^st place

ahajournals.org

Dusman RE, Stanton MS, Miles WM et al. Clinical features of amiodarone-induced pulmonary toxicity, Circulation, 1990;82:51–9
Tsaban G, Ostrovsky D, Alnsasra H et al. Amiodarone and pulmonary toxicity in atrial fibrillation: a nationwide Israeli study, European Heart Journal, 2024;45:379–388

circ.ahajournals.org

Wellens HJ, Brugada P, Abdollah H et al. A comparison of the electrophysiologic effects of intravenous and oral amiodarone in the same patient, Circulation, 1984;69:120–124

bmj.com

heart.bmj.com

(en) van Erven L, Schalij MJ, Clinical pharmacology: Amiodarone: an effective antiarrhythmic drug with unusual side effects, Heart, 2010;96:1593-1600

endocrine.org

press.endocrine.org

Godley A. F & Stanbury JB. (1954). Preliminary experience in the treatment of hyperthyroidism with potassium perchlorate. The Journal of Clinical Endocrinology & Metabolism, 14(1), 70-78 (résumé)

nature.com

(en) Becquemont L, Neuvonen M, Verstuyft C et al. Amiodarone interacts with simvastatin but not with pravastatin disposition kinetics, Clin Pharmacol Ther, 2007;81:679–684.

nejm.org

(en) Singh BN, Singh SN, Reda DJ et al. Amiodarone versus sotalol for atrial fibrillation, N Engl J Med, 2005;352:1861–72
(en) Roy D, Talajic M, Dorian P et al. Amiodarone to prevent recurrence of atrial fibrillation. Canadian Trial of Atrial Fibrillation Investigators, N Engl J Med, 2000;342:913–18.
(en) Singh SN, Fletcher RD, Fisher SG et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia, N Engl J Med, 1995;333:77–82
(en) Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure, N Engl J Med, 2005;352:225–237

nih.gov

ncbi.nlm.nih.gov

(en) Meng X, Mojaverian P, Doedee M et al. Bioavailability of amiodarone tablets administered with and without food in healthy subjects, Am J Cardiol, 2001;87:432–435
(en) Buchinger W, Lorenz-Wawschinek O, Semlitsch G et al. Thyrotropin and thyroglobulin as an index of optimal iodine intake: correlation with iodine excretion of 39,913 euthyroid patients, Thyroid, 1997;7:593–7
(en) Piccini JP, Hasselblad V, Peterson ED, Washam JB, Califf RM, Kong DF, Comparative efficacy of dronedarone and amiodarone for the maintenance of sinus rhythm in patients with atrial fibrillation, J Am Coll Cardiol, 2009;54:1089-1095
(en) Siniakowicz RM, Narula D, Suster B, Steinberg JS, Diagnosis of amiodarone pulmonary toxicity with high-resolution computerized tomographic scan, J Cardiovasc Electrophysiol, 2001;12:431– 436
Reichert LJ & De Rooy HA(1989) Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ: British Medical Journal, 298(6687), 1547 (résumé).

onlinejacc.org

content.onlinejacc.org

(en) Kaufman ES, Zimmermann PA, Wang T, Dennish GW III et al. Risk of proarrhythmic events in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study: a multivariate analysis, J Am Coll Cardiol, 2004;44:1276–1282

qmul.ac.uk

chem.qmul.ac.uk

Masse molaire calculée d’après « Atomic weights of the elements 2007 », sur www.chem.qmul.ac.uk.

sciencedirect.com

Khan IA, Mehta NJ, Gowda RM, Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation, Int J Cardiol, 2003;89:239–248
Hudig F, Bakker O, Wiersinga WM, Amiodarone decreases gene expression of low‐density lipoprotein receptor at both the mRNA and the protein level, Metabolism, 1998;47:1052–7

springer.com

link.springer.com

Schwaiblmair M, erghaus T, Haeckel T, Wagner T, von Scheidt W, Amiodarone-induced pulmonary toxicity: an under-recognized and severe adverse effect?, Clin Res Cardiol, 2010;99:693–700

surveyophthalmol.com

(en) Mantyjarvi M, Tuppurainen K, Ikaheimo K, Ocular side effects of amiodarone, Surv Ophthalmol, 1998;42:360–6

who.int

apps.who.int

WHO Model List of Essential Medicines, 18th list, avril 2013

wiley.com

onlinelibrary.wiley.com

Simonen P, Lehtonen J, Lampi A‐M, Piironen V, Stenman U‐H, Kupari M, Gylling H, Desmosterol accumulation in users of amiodarone, J Intern Med, 2018;283:93–101